ABVIRO LLC
BETHESDA, Maryland
Total Received
$40.5M
Total Awards
2
State
Maryland
Last Updated
Mar 24, 2026
Yearly Funding Trend
$40.5M24
Top 2 Awards to ABVIRO LLC
Largest individual federal awards on record for this recipient, ranked by obligated amount. Data through March 24, 2026.
| Award | Awarding Agency | Program | Place | FY | Obligation |
|---|---|---|---|---|---|
CONT_AWD_HHSN272201600028C_7529_-NONE-_-NONE- THE PURPOSE OF THIS CONTRACT IS TO DEVELOP A MONOCLONAL ANTIBODY (MAB) AV-1 AS A SAFE INJECTABLE THERAPEUTIC. | Department of Health and Human Services National Institutes of Health | — | BETHESDA, MD-08 | 2024 | $29,175,011 |
CONT_AWD_75N93023C00055_7529_-NONE-_-NONE- TO CONDUCT A PHASE 2 DENGUE HUMAN CHALLENGE CLINICAL TRIAL OF ABVIRO ANTI-DENGUE MONOCLONAL ANTIBODY (MAB) AV-1. | Department of Health and Human Services National Institutes of Health | — | BETHESDA, MD-08 | 2024 | $11,335,102 |
Top 2 awards shown, ranked by obligated amount. Dates reflect performance period; last-modified dates match USAspending.gov. Complete listings include all transaction history going back to FY2024.
Funding Agencies
View All→Source: USAspending.gov · All Recipients · Maryland